This website uses cookies. By continuing you are agreeing to our privacy policy.

Griffith Parks, Ph.D.

Griffith Parks
University of Central Florida
Novel Oncolytic Virus for Redirecting NK Cell Killing of Lung Cancer Cells
Lung Cancer Discovery Award

Viruses are now being used as anti-cancer agents. We will design a cancer therapy based on a virus called parainfluenza virus 5, which naturally infects the respiratory tract but is not associated with human disease. Using a mouse model system, we will combine a mutant version of parainfluenza virus which is specific for lung tumor cells and a type of normal human immune cell called Natural Killer (NK) cells, which recognize cancer cells and kill them. Through this combined approach we will harness the immune system's ability to recognize this novel virus to aid in clearance of lung cancer cells.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.